Provention Bio, Inc. Quarterly Assets, Current in USD from Q4 2019 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Provention Bio, Inc. quarterly Assets, Current history and growth rate from Q4 2019 to Q4 2022.
Provention Bio, Inc. Assets, Current for the quarter ending December 31, 2022 was $175M, a 72.8% increase year-over-year.

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$175M	+$73.6M	+72.8%	Dec 31, 2022	10-K	2023-03-29
Q3 2022	$190M	+$35.2M	+22.7%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$90.3M	-$90.3M	-50%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$91.8M	-$120M	-56.6%	Mar 31, 2022	10-Q	2022-05-05
Q4 2021	$101M	-$25.5M	-20.1%	Dec 31, 2021	10-K	2023-03-29
Q3 2021	$155M	+$3.93M	+2.6%	Sep 30, 2021	10-Q	2021-11-04
Q2 2021	$181M			Jun 30, 2021	10-Q	2021-08-05
Q1 2021	$212M			Mar 31, 2021	10-Q	2021-05-06
Q4 2020	$127M	+$40.6M	+47.2%	Dec 31, 2020	10-K	2022-02-24
Q3 2020	$151M			Sep 30, 2020	10-Q	2020-11-05
Q4 2019	$86M			Dec 31, 2019	10-K	2021-02-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.